SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
1-Year Return
5.3%
This Quarter Return
+13.1%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$273M
AUM Growth
+$58.5M
(+27%)
Cap. Flow
+$37.2M
Cap. Flow
% of AUM
13.63%
Top 10 Holdings %
Top 10 Hldgs %
31.23%
Holding
76
New
17
Increased
24
Reduced
16
Closed
9
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$9.26M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$7.3M |
| 3 |
Gilead Sciences
GILD
|
$6.37M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$4.91M |
| 5 |
AbbVie
ABBV
|
$4.35M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$6.73M |
| 2 |
Zimmer Biomet
ZBH
|
$4.88M |
| 3 |
Bristol-Myers Squibb
BMY
|
$4.21M |
| 4 |
Tenet Healthcare
THC
|
$3.99M |
| 5 |
AstraZeneca
AZN
|
$3.89M |
Sector Composition
| 1 | Healthcare | 87.53% |
| 2 | Financials | 2.5% |
| 3 | Energy | 1.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Agilent Technologies
A
$36.5B
| $4.75M | 1.74% |
80,000
-10,000
| -11% | -$593K |
|
27
Thermo Fisher Scientific
TMO
$185B
| $4.36M | 1.6% |
25,000
| – | – |
|
|
28
AbbVie
ABBV
$375B
| $4.35M | 1.59% |
+60,000
| New | +$4.35M |
|
29
Bausch Health
BHC
$2.67B
| $4.24M | 1.55% |
245,000
+45,000
| +23% | +$779K |
|
30
Stryker
SYK
$150B
| $4.16M | 1.52% |
+30,000
| New | +$4.16M |
|
|
IPXL
31
DELISTED
Impax Laboratories, Inc.
IPXL
| $4.03M | 1.47% |
250,000
+81,970
| +49% | +$1.32M |
|
32
Cardinal Health
CAH
$35.6B
| $3.9M | 1.43% |
50,000
+15,000
| +43% | +$1.17M |
|
33
Perrigo
PRGO
$3.18B
| $3.4M | 1.24% |
45,000
+20,000
| +80% | +$1.51M |
|
|
HRC
34
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $3.18M | 1.17% |
+40,000
| New | +$3.18M |
|
35
Smith & Nephew
SNN
$16.4B
| $3.14M | 1.15% |
90,000
+20,000
| +29% | +$697K |
|
36
Medtronic
MDT
$119B
| $3.11M | 1.14% |
+35,000
| New | +$3.11M |
|
|
LHCG
37
DELISTED
LHC Group LLC
LHCG
| $3.06M | 1.12% |
45,000
-4,405
| -9% | -$299K |
|
38
HCA Healthcare
HCA
$96.2B
| $3.05M | 1.12% |
35,000
-17,500
| -33% | -$1.53M |
|
39
Universal Health Services
UHS
$11.7B
| $3.05M | 1.12% |
25,000
-17,500
| -41% | -$2.14M |
|
40
Intuitive Surgical
ISRG
$163B
| $3.04M | 1.11% |
29,250
+9,000
| +44% | +$935K |
|
|
GWPH
41
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.01M | 1.1% |
30,000
-5,200
| -15% | -$521K |
|
|
AMED
42
DELISTED
Amedisys
AMED
| $2.8M | 1.03% |
44,607
+10,000
| +29% | +$628K |
|
|
ENDP
43
DELISTED
Endo International plc
ENDP
| $2.79M | 1.02% |
+250,000
| New | +$2.79M |
|
|
VAR
44
DELISTED
Varian Medical Systems, Inc.
VAR
| $2.58M | 0.94% |
+25,000
| New | +$2.58M |
|
45
Globus Medical
GMED
$8.12B
| $2.56M | 0.94% |
+77,340
| New | +$2.56M |
|
46
Chemed
CHE
$6.69B
| $2.56M | 0.94% |
12,500
-2,500
| -17% | -$511K |
|
47
Acadia Healthcare
ACHC
$2.17B
| $2.47M | 0.9% |
50,000
| – | – |
|
48
Community Health Systems
CYH
$397M
| $2.19M | 0.8% |
+220,000
| New | +$2.19M |
|
|
TSRO
49
DELISTED
TESARO, Inc.
TSRO
| $2.1M | 0.77% |
15,000
+4,500
| +43% | +$629K |
|
50
Assertio
ASRT
$76.8M
| $1.93M | 0.71% |
+45,000
| New | +$1.93M |
|